
Sign up to save your podcasts
Or


Sophia Davis talks to Mikkel Højlund about research into the prevalence and outcomes of antipsychotics polypharmacy.
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
By The Lancet GroupSophia Davis talks to Mikkel Højlund about research into the prevalence and outcomes of antipsychotics polypharmacy.
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

154 Listeners

660 Listeners

1,337 Listeners

285 Listeners

91 Listeners

564 Listeners

17 Listeners

21 Listeners

0 Listeners

0 Listeners

2 Listeners

1 Listeners

1 Listeners

1 Listeners

0 Listeners

0 Listeners

1 Listeners

1 Listeners

1 Listeners

0 Listeners

0 Listeners

0 Listeners

193 Listeners

0 Listeners

0 Listeners

0 Listeners

0 Listeners